A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma

NCT00290706 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Closed per Data Monitoring Committee due to lack of efficacy

Conditions

Lymphoma

Interventions

DRUG: bortezomib
DRUG: gemcitabine hydrochloride

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]